CLINICAL_TRIALS
trial_result
· 2014-08-20
Clinical Trial Update: Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP [Phase 2]
Summary
Phase 2 trial update reporting results of rapid intravenous immunoglobulin (IVIG) infusion in patients with immune thrombocytopenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Grifols Therapeutics LLC | Conditions: Purpura, Thrombocytopenic, Idiopathic | Phase 2 | Status: COMPLETED | Results posted: 2014-08-20